Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2-), node negative breast cancer in the randomized TAILORx trial: gaps in biologic and social determinants of health.

ABSTRACT:

SUBMITTER: Beltran-Bless AA 

PROVIDER: S-EPMC9843404 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature